Natera, Inc.
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Weighted-Average Remaining Lease Term by Year
Weighted-Average Remaining Lease Term — Operating Leases (years) (years)
Natera Weighted-Average Remaining Lease Term: 6.9 years in FY2025, down 11.5% from a year earlier.
Latest, FY2025
6.9
Period ended Dec 31, 2025
Change on a year earlier
-11.5%
7.8 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (2026-02-27) ↗
Reported in Form 10-K/10-Q Note — Leases (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Weighted-Average Remaining Lease Term — Operating Leases (years) (years) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6.9 | -11.5% | Form 10-K (2026-02-27) ↗ |
| FY2024 | Dec 31, 2024 | 7.8 | +16.4% | Form 10-K (2025-02-28) ↗ |
| FY2023 | Dec 31, 2023 | 6.7 | -10.7% | Form 10-K (2024-02-29) ↗ |
| FY2022 | Dec 31, 2022 | 7.5 | +56.3% | Form 10-K (2023-03-01) ↗ |
| FY2021 | Dec 31, 2021 | 4.8 | +108.7% | Form 10-K (2022-02-25) ↗ |
| FY2020 | Dec 31, 2020 | 2.3 | -23.3% | Form 10-K (2021-02-26) ↗ |
| FY2019 | Dec 31, 2019 | 3.0 | – | Form 10-K (2020-03-02) ↗ |
Cite this data
StockData. (2026). Natera Weighted-Average Remaining Lease Term (years), annual FY2019–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/lease-weighted-avg-remaining-term-yrs
See every metric in the Natera KPI table. Data updated Nov 2, 2026.